In re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456 (D. Mass.); City of New York v. Abbott Laboratories, No. 01-cv-12257 (D. Mass.).
                Case Overview
| Status: | Status: Settled | 
| Related Practices: | Related Practices: Antitrust, Healthcare Fraud | 
 In re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456; City of New York v. Abbott Laboratories, No. 01-cv-12257 (D. Mass. 2010).  KM represented the State of Iowa, the City of New York, and forty-two New York State counties in a lawsuit against forty defendant drug manufacturers asserting that they manipulated their average wholesale price data to inflate prices charged to government drug benefits payers.  Recovery of over $225 million for the plaintiffs.